Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Perhaps someone knows something
It's on the move now, just ticked up again.
About the time the move up after so many buys since yesterday, it has kept down despite the many buys
Not so sure, it could gap up quickly given the correct conditions. That maybe this months fda update, or possible any news/progress on chronocort
Every day dnl gets more bullish on the candles . IMO lets get 60p out the way properly no rush to form a nice base AND I FEEL 70P WILL BE HIT SOON AS THE BASE
Hi BOJO2020
Thank you, I read up on many other companies and pick very few, but DNL just stood out. My hope is that the confidence shown by Eton getting out in front of the FDA decision and the Hardman Report being quietly confident that the decision seems to be a dotting the i's and crossing the t's exercise, is well founded. Being new to the share I feel I'm taking a calculated risk in buying in at this price level. Even so I have confidence that DNL is going to grow rapidly over the next 2 years.
Also news over in SCLP would be nice to hear.
Chester.
chester 18,
Nice to see you here as well as SCLP. I, like you, missed the rise to 60p here. Never the less this looks like a well-organised company with good potential over the medium or long term. Just like our other investment, it seems to be flying under the radar somewhat but I guess there are plenty of LTH just waiting for some great news. Good luck with this investment :-) forward to your
Longterm kind thanks very intresting. Imo we are on to a winner here
Courtesy of the other bb.. some New broker research
https://www.calvinepartners.com/research
Also worth noting that DNL have shares in ETON which was part of the deal, Which have almost doubled in value. Eton Are estimating the market size being 100 million, where diurnal have it at 30 million for akindl. On Etons trading update they were very, very positive on FDA approval and plan executing sales almost immediately.
HI chester i am convinced dnl can deliver . i started buying at 30p sold at 64 as a quick rise . Had some trades here but not any more as i feel this will hit 2 pound in time .Atb lets hope we are all happy
scoredagainsteps
Big decision on the watch you must be convinced. I'm normally in a company at the early stages but I can see all the years of work by DNL to this point and I don't mind paying the 60p because a lot of the 'what ifs' have been dealt with.
Time will tell but I am assured by the details in the Hardman report and as I said reading back on this board has also helped. I just hope that the FDA give the green light as that does open up all the positives for a great 2021 and beyond.
Thank you, the three reply's have really helped me.
Chester.
HunSen
Thank you for your input. When I read that Eton had made the decision to act as the approval was a done deal and take in stock ready to launch I thought that was a very clear signal. Partly why I've bought the shares I have. Given that the decision is positive it really does set up 2021 to be a very exciting year.
Thank you for the note about the presentation tomorrow.
Chester.
I love this little company imo 60p will be forgotten soon . I have just used some money i had put to one side for a watch to buy another 10000 plus HERE . Hopefully next few months we will rerate and find true value . IM top heavy here but i like the bit they are trying for japan and china markets. THAT will really add value here . IM in other pharmas but this one ticks all the boxes for me
Hi L0ngterm
Yes I noticed that Richard Griffiths was a share holder, he has taken a 12% slice of TRX that I hold. Some on that board said RG does like to buy in early and then leave once he feels there is another opportunity to see high multiple growth he's off. Maybe he likes his money doubled to trebled as quickly as possible.
Does seem a shame when there is good news about to happen.
I do think DNL have everything set up to create good yearly growth and profits.
thank you for you response
Chester.
Hi Chester,
I think the FDA isn't a done deal yet (but, I read recently that the FDA said "we need this drug" or something along these lines). If you look at the long term share graph, you can see an FDA rejection, I believe there was a statistical error in that FDA submission, but perhaps investors have a memory of this.
In addition, it is not so much a new drug, but it is a new delivery method for an existing drug - so there should be no real reason for the FDA to reject this.
It is true that Richard Griffiths has been a seller, but he does manage a fund and perhaps the % holding became too high as the SP has increased - he is a bit of an unknown. Or perhaps he is looking at other opportunities.
I have increased my holding in the last year and I have confidence in this company.
FDA approval will be a huge step, putting the company on course to be profitable by 2022.
The CEO is presenting online tomorrow (look at threads further down for the link).
ALB
Basically a major shareholder has been reducing there holding ( Richard Griffith’s). Beyond that, some may say this is a boring share, and by boring and this is purely IMHO, the company has successfully mapped out and delivered thus far on its pipeline for this year,. it’s is not chasing 10 billlion dollar markets, shiny objects etc. The biggest question is the direction the company is taking and will progress with chronocort, if successful with progress and European approval this should look significantly different.
I have just made my first purchases of DNL after reading some of the recent posts on here and the Hardman Report from 20th August. I really like all the fundamentals and feel its a good time to invest for the longer term.
I am puzzled as to why there is so much appetite to sell when the announcement from the FDA is a main part of the critical path towards growth and the success of the Eton deal.
Because I am so new to the share I find it strange that there is not a stronger air of excitement so it leads me to wonder if there is something I don't appreciate in the details of the upcoming decision day, which means there is a concern that its not going to happen !
Could someone on the board give me a heads up as to what would currently motivate sells.
I would really appreciate some reply's, thank you.
Chester.
( If you wish to check my background I am mostly on, SCLP, GGP, TRX and RENE )